Option Care Health

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Option Care Health surpasses Q4 expectations, eyes growth opportunities

Option Care Health's Q4 performance reflects growth and resilience amidst inflation challenges. The company's financial strength, focus on efficiency, and strategic initiatives position it well for future expansion and value creation.

Option Care Health reports robust Q2 earnings amidst strategic growth focus

Option Care Health's Q2 2023 earnings call highlighted strong financial performance, with revenue growth and adjusted EBITDA exceeding expectations. The company's strategic initiatives focus on innovation, operational efficiency, and patient care excellence.
While facing challenges like reimbursement issues and cost pressures, Option Care Health remains optimistic about sustainable growth and shareholder value. Investments in capabilities and network expansion position the company for future opportunities.
Analysts' inquiries into revenue growth composition, cost challenges, and future outlooks were addressed with a focus on operational excellence and sustainable growth. Option Care Health's performance reflects a balance of financial strength and strategic vision.

Option Care Health excels in Q3 performance and eyes M&A for growth

Option Care Health's Q3 earnings call highlighted strong financial performance, successful collaboration, and strategic focus on M&A for shareholder value. Challenges include revenue pressure in Q4 and sustainability of procurement benefits for 2024 projections.

Option Care Health exceeds revenue expectations, eyes strategic growth

Option Care Health's strong financial performance in 2023 positions the company for continued growth.
Strategic initiatives, operational efficiencies, and engagement with payers highlight the company's resilience.
Navigating market dynamics, optimizing procurement benefits, and strategic growth remain key focus areas for 2024.

Option Care Health reports resilient Q1 performance and growth opportunities

Option Care Health's Q1 2024 performance showcased revenue growth, strong patient satisfaction, and resilience in maintaining financial strength.
Despite challenges from the cybersecurity incident and supply chain disruptions, the company remains focused on growth and operational improvements.
Opportunities lie in expanding services, portfolio diversification, and adapting to evolving patient needs for continued success in 2024.
With disciplined SG&A management and a commitment to patient care, Option Care Health is poised for growth and service expansion.

Option Care Health excels in Q2, boosts revenue outlook

Option Care Health's Q2 performance reflects resilience and strategic focus, driving revenue growth and operational efficiency.
Despite challenges, the company's strengths in financial management and capital deployment position it well for future opportunities.
With increased revenue expectations and a strong cash flow rebound, Option Care Health is poised for sustained growth and value creation.

Option Care Health reports resilient Q3 performance amid operational challenges

Option Care Health's Q3 2024 performance showcased growth and financial resilience amidst operational challenges.
The company's strategic focus on managing costs and pursuing growth initiatives positions it well to address upcoming gross margin pressures.
Despite facing headwinds, Option Care Health remains optimistic about its revenue outlook for the full year 2024 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BANNOCKBURN, Ill., March 15, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 12,000,000 shares of the Company's common stock at a price to the public of $20.00 per share in an underwritten public offering. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 1,800,000 additional shares of common stock. The offering is expected to close on March 17, 2021, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Option Care Health Announces Pricing of Secondary Offering of 12,000,000 Shares of Common Stock

BANNOCKBURN, Ill., March 15, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 12,000,000 shares of the Company's common stock in an underwritten public offering. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 1,800,000 additional shares of common stock. The Company will not receive any proceeds from the offering.

Option Care Health Announces Secondary Offering of 12,000,000 Shares of Common Stock

Option Care Health's (OPCH) CEO John Rademacher on Q4 2020 Results - Earnings Call Transcript

Is (OPCH) Outperforming Other Medical Stocks This Year?

Is Option Care Health (OPCH) Outperforming Other Medical Stocks This Year?

Option Care (OPCH) delivered earnings and revenue surprises of 42.86% and 0.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Q4 Earnings and Revenues Beat Estimates

Shares of Option Care Health (NASDAQ:OPCH) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share rose 211.11% year over year to $0.10, which beat the estimate of $0.07.

Recap: Option Care Health Q4 Earnings

BANNOCKBURN, Ill., March 11, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2020.

Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2020 and Provides Guidance for Full Year 2021

Option Care (OPCH) closed at $19.54 in the latest trading session, marking a -1.19% move from the prior day.

Option Care (OPCH) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Option Care (OPCH) closed at $18.97, marking a +0.58% move from the previous day.

Option Care (OPCH) Outpaces Stock Market Gains: What You Should Know

Option Care (OPCH) closed the most recent trading day at $19.86, moving +0.2% from the previous trading session.

Option Care (OPCH) Gains As Market Dips: What You Should Know

Madison Dearborn Partners will sell 15 million common shares of Option Care Health Inc (NASDAQ: OPCH) at $18.50 per share in an underwritten public offering. OPCH will not receive any proceeds from the offering.

Madison Dearborn To Reduce Stake In Option Care Health

BANNOCKBURN, Ill., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, announced today preliminary financial results for the fourth quarter and fiscal year ended December 31, 2020.

Option Care Health Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year and Schedules Fourth Quarter Earnings Call

BANNOCKBURN, Ill., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: OPCH)(“Option Care Health” or the Company”), the nation's largest independent home and alternate site infusion services provider, announced today that it has successfully issued $250 million in additional first lien term loans, the proceeds from which were used to extinguish the entire $246 million remaining outstanding balance of the Company's second lien notes.

Option Care Health Announces Issuance of $250 Million in Additional First Lien Term Loan and Concurrent Extinguishment of All Outstanding Second Lien Notes

BATON ROUGE, La., and BANNOCKBURN, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, and Option Care Health Inc. (NASDAQ: OPCH), the nation's largest independent home and alternate site infusion services provider, are collaborating on providing COVID antibody infusion therapy within skilled nursing and assisted living facilities, collectively referred to as “long term care facilities.” The U.S Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs) to both Eli Lilly and Regeneron for their investigational neutralizing antibody therapies to treat mild to moderate COVID-19 in adults and pediatrics who are at high risk for progressing to severe COVID-19 symptoms or hospitalization.

Leading Healthcare Services Organizations Collaborate to Provide Innovative COVID Therapy Access Model

BANNOCKBURN, Ill., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 10,000,000 shares of the Company's common stock at a price to the public of $15.00 per share in an underwritten public offering. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 1,500,000 additional shares of common stock. The offering is expected to close on December 14, 2020, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Option Care Health Announces Pricing of Secondary Offering of 10,000,000 Shares of Common Stock

As of late, it has definitely been a great time to be an investor in Option Care Health (OPCH).

Option Care Health's (OPCH) Shares March Higher, Can It Continue?

Option Care Health, Inc. (OPCH) CEO John Rademacher on Q3 2020 Results - Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of 125.00% and 7.41%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

News for Option Care Health Stock (OPCH)